BriaCell Therapeutics

(NASDAQ) BCTX

Current Price$4.12

Market Cap$30.31M

Since IPO (2014)-100%

5 YearN/A

1 Year-91%

1 Month-0%

BriaCell Therapeutics Financials at a Glance

Market Cap

$30.31M

Revenue (TTM)

$0.00

Net Income (TTM)

$38.50M

EPS (TTM)

$-27.63

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$4.12

Volume

612

Open

$4.12

Price

$4.12

Volume

612

Open

$4.12

Previous Close

$4.12

Daily Range

$4.12 - $4.16

52-Week Range

$3.60 - $41.30

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$4.12

Volume

612

Open

$4.12

Previous Close

$4.12

Daily Range

$4.12 - $4.16

52-Week Range

$3.60 - $41.30

BCTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BriaCell Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

William V. Williams, MD

Website

www.briacell.com

Headquarters

West Vancouver, BC V7T 2X1, CA

BCTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-172%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$30.31M

Shares Outstanding

7.25M

Volume

612

Avg. Volume

194.94K

Financials (TTM)

Gross Profit

$147.89K

Operating Income

$37.73M

EBITDA

$36.63M

Operating Cash Flow

$39.07M

Capital Expenditure

$3.08

Free Cash Flow

$39.07M

Cash & ST Invst.

$24.56M

Total Debt

$0.00

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$27.14K

+29.3%

Gross Margin

0.00%

N/A

Market Cap

$30.31M

N/A

Market Cap/Employee

$1.89M

N/A

Employees

N/A

Net Income

$7.35M

+18.9%

EBITDA

$7.64M

+16.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$29.90M

+304.7%

Accounts Receivable

$3.09M

-2.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.29%

N/A

Return on Invested Capital

-1.24%

N/A

Free Cash Flow

$8.11M

+5.2%

Operating Cash Flow

$8.11M

+5.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LPTXLeap Therapeutics, Inc.

LPTXLeap Therapeutics, Inc.$0.77-3.15%

ALLRAllarity Therapeutics, Inc.

ALLRAllarity Therapeutics, Inc.$1.30-3.70%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

HOTHHoth Therapeutics, Inc.

HOTHHoth Therapeutics, Inc.$0.73-2.01%

CTXRCitius Pharmaceuticals, Inc.

CTXRCitius Pharmaceuticals, Inc.$0.70+0.57%

CRISCuris, Inc.

CRISCuris, Inc.$0.59-1.33%

PCSAProcessa Pharmaceuticals, Inc.

PCSAProcessa Pharmaceuticals, Inc.$2.55-5.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

MARAMara Holdings

MARAMara Holdings$11.46-0.04%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.84+0.01%

Questions About BCTX

What is the current price of BriaCell Therapeutics?

BriaCell Therapeutics is trading at $4.12 per share.

What is the 52-week range for BriaCell Therapeutics?

Over the past 52 weeks, BriaCell Therapeutics has traded between $3.60 and $41.30.

How much debt does BriaCell Therapeutics have?

As of the most recent reporting period, BriaCell Therapeutics reported total debt of N/A.

How much cash does BriaCell Therapeutics have on hand?

BriaCell Therapeutics reported $29.90M in cash and cash equivalents in its most recent financial results.

What is BriaCell Therapeutics’s dividend yield?

BriaCell Therapeutics does not currently have a dividend yield.

BriaCell Therapeutics

BriaCell Therapeutics Financials at a Glance

BCTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BriaCell Therapeutics

BCTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCTX

What is the current price of BriaCell Therapeutics?

What is the 52-week range for BriaCell Therapeutics?

How much debt does BriaCell Therapeutics have?

How much cash does BriaCell Therapeutics have on hand?

What is BriaCell Therapeutics’s dividend yield?

Premium Investing Services